Background Against the backdrop of targeted therapy and immune checkpoint inhibitors (ICIs), the additional benefit of combining TACE and HAIC remains uncertain in unresectable hepatocellular carcinoma (uHCC). We separately evaluated TACE-based and HAIC-based comparator strategies. Methods CNKI, the Cochrane Library, E...
Pei-Zhuo Li, Hao Li, Bo-Yuan Mei et al.· Frontiers in Oncology· 0 citations
This review systematically summarizes the molecular mechanisms and common pathways through which PTMs contribute to therapeutic resistance in liver cancer, explores PTM-mediated mechanism underlying tumor persistence and distant recurrence, andamines how PTM-targeted strategies may reverse resistance.
Si-Min Feng, Jie Hu, Xiao-Xi Guo et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.